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Summary We present a patient with new onset temporal lobe epilepsy and
cognitive decline in his sixth decade with unilateral hippocampal atrophy on struc-
tural brain imaging, compatible with mesial temporal sclerosis. This unusual clinical
scenario presented a challenging differential diagnosis since it may overlap with
primary cognitive disorders, including early-onset Alzheimer’s disease and some forms
of frontotemporal dementia, and the recently elucidated syndrome of non-paraneo-
plastic limbic encephalitis associated with voltage-gated potassium channel anti-
bodies.
# 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Symptomatic temporal lobe epilepsy (TLE) with the
neuroradiological signature of hippocampal or
mesial temporal sclerosis (MTS), namely hippocam-
pal atrophy on coronal T1-weighted magnetic reso-
nance imaging (MRI), with or without high signal in
the hippocampus on T2-weighted or FLAIR images, is
thought to be the commonest form of localization-
related epilepsy.1,2 The majority of patients, up to
90%, with TLE—MTS have a history of a precipitating* Corresponding author. Tel.: +44 151 529 5727;
fax: +44 151 529 8552.
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doi:10.1016/j.seizure.2007.12.001incident such as febrile convulsions, brain trauma,
ischaemia, or intracranial infection.3 Genetic fac-
tors may also contribute: mutation of the alpha1
subunit of the voltage-gated sodium channel gene
has been identified in a subgroup of patients with
febrile convulsions and subsequent TLE.4 In families
with another inherited form of TLE, symptomatic
and asymptomatic probands were shown to have
MTS.5
In TLE—MTS, the first non-febrile seizure typically
occurs between 4 and 16 years of age.2 Onset after
early adulthood is extremely unusual. We present a
patient with late-onset TLE and focal cognitive
deficits with neuroradiological evidence of unilat-
eral MTS that fits into none of these recognised
categories.. Published by Elsevier Ltd. All rights reserved.
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A 60-year-old right-handed retired builder pre-
sented to the Epilepsy Clinic with several witnessed
generalized tonic—clonic seizures over an 8-month
period. Attacks occurred without warning, and were
followed by 2—3 h of postictal confusion and irrit-
ability. They occurred in clusters of three to five, in
the early hours of the morning, some arising directly
from sleep. Two clusters led to hospital admission,
one requiring a period of endotracheal intubation
and ventilation on an intensive care unit for several
days. During another seizure the patient sustained a
shoulder injury which required reconstructive sur-
gery. There was no prior history of events compa-
tible with partial seizures or childhood febrile
convulsions, and no family history of epilepsy. The
only identified risk factor for epilepsy was alcohol
consumption of 28 units over weekends, but the
patient denied binge drinking prior to seizures.
In addition to seizures, the patient complained of
being more forgetful in recent months. Examples
recounted by him and his family included losing
items (wallet, glasses), forgetting to pass on mes-
sages, and buying items already bought (e.g. news-
papers). In addition, he reported difficulty recalling
episodes from his earlier life, such as time spent in
the armed forces, previous occupations, and foreign
holidays.
Investigations included an interictal EEG which
showed baseline alpha rhythmwith occasional theta
components but no epileptiform discharges. Non-
enhanced MR brain imaging showed marked right
hippocampal atrophy on coronal T1-weighted
sequences, compatible with right mesial temporal
sclerosis; no signal change was seen on T2-weighted
or FLAIR images.
Neuropsychological assessment showed general
memory functioning within the borderline
range (WMS III score 75; 5th percentile) with
evidence of significant decline when compared
to predicted premorbid level of intellectual func-
tioning (WTAR predicted 88). Impairments were
evident in tests of both immediate and delayed
memory (extremely low to average function),
particularly in visual delayed memory (WMS II
68, 2nd percentile). Comparing delayed and
immediate memory performance suggested a
rapid rate of forgetting for visual but not auditory
information.
He was treated with carbamazepine (600 mg/
day) with cessation of seizures. He also felt that
his forgetfulness improved after commencing anti-
epileptic drug therapy, an impression corroborated
by family, but he declined a further neuropsycho-
logical assessment.Discussion
This patient’s presentation with secondarily gener-
alised seizures, cognitive decline, and MR imaging
evidence of unilateral hippocampal atrophy, was
compatible with the diagnosis of TLE-MTS. However,
the age of presentation (60) was unusual since most
cases of TLE-MTS present between childhood and
early adulthood. Late-onset TLE—MTS has been
reported as a consequence of a meningitic illness
due to neurocysticercosis,6 but no precipitating ill-
ness was reported in our patient.
The precise role of MTS in our patient’s clinical
syndrome is uncertain: itmay have been the common
aetiology of both the seizures and cognitive decline,
alternatively the acquired cognitive impairmentmay
have resulted from the seizures per se. Repeat neu-
ropsychological assessment following seizure cessa-
tion might have been helpful in deciding between
these possibilities. The subjective impression of
memory improvement may suggest that cognitive
impairment was directly related to seizures.
In view of the age at onset and the clinical
symptoms suggestive of both anterograde and retro-
grade amnesia, the differential diagnosis in this
patient encompassed not only a seizure disorder
but also a primary cognitive disorder of neurode-
generative or autoimmune aetiology.
Early-onset Alzheimer’s disease (AD) is the com-
monest cause of amnesia at this age. Although
seizures, usually secondarily generalised, become
more prevalent with AD progression, nonetheless
they may be present at the time of diagnosis without
explanation other than symptomatic AD.7 Cases of
TLE with frequent seizures sufficient to cause mem-
ory decline simulating AD have been reported.8,9
Pure hippocampal sclerosis (PHS), an increasingly
recognised cause of late-life cognitive decline some-
times associated with seizures,10—12 also enters the
differential diagnosis. This condition was initially
defined on neuropathological grounds with neuronal
loss in the hippocampal CA1 region. The appearances
may look quite similar to seizure-associated MTS,12
where the neuropathological substrate is neuronal
dropout and astrocytosis in the granule cell layer of
the dentate gyrus and hilar region with loss of pyr-
amidal cells in the CA1 and CA3 regions, but with
sparing of pyramidal cells in the CA2 region, subicu-
lum, entorhinal cortex and temporal neocortex.2 The
neuroradiological signature of PHS is hippocampal
atrophy.13 In some cases, PHS may be strictly uni-
lateral.12 Initially, the clinical overlap between PHS
and AD was emphasized, with a similar prevalence of
seizures reported;12 intractable seizures with cogni-
tive decline was the presentation in one case.14 More
recently, however, many cases of PHS have been
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(FTD) based on the clinical and neuropsychiatric
features, and the neuropathological finding of tau-
negative ubiquitin-positive inclusions.15,16 However,
seizures are not generally considered a feature of
other forms of FTD.
Another possibility which we believe merits con-
sideration in this case is prompted by recent findings
of persistent amnesia and focal medial temporal
lobe atrophy following non-paraneoplastic limbic
encephalitis (NPLE) associated with voltage-gated
potassium channel (VGKC) antibodies.17,18 This syn-
drome, most commonly seen in patients over 50,
may easily be misdiagnosed as dementia, and hence
may be underdiagnosed. Marked recovery fromNPLE
may be seen after immunotherapy, although spon-
taneous improvement has been recorded,17,18
prompting us to question whether our patient’s
ITU admission with seizures may have been a missed
diagnosis of NPLE. Antibody-mediated paraneoplas-
tic limbic encephalitis (e.g. with anti-Ta antibodies
associated with seminoma) may also cause focal
brain atrophy and seizures, but is a less likely pos-
sibility in our patient because of the spontaneous
remission. Intermittent seizures prior to diagnosis of
VGKC antibody-mediated NPLE has been reported.19
Retrograde amnesia extending prior to the acute
illness may be a sequela of NPLE. Rare cases of focal
(isolated) retrograde amnesia20 with a prior history
of ‘‘encephalitis’’ and seizures or with focal brain
atrophy21,22 might also be sequelae of such an
inflammatory process. However, retrospective assay
for VGKC antibodies would probably be uninforma-
tive in both these situations since antibody titre falls
with recovery from the acute illness.17Conclusion
Late-onset secondarily generalised seizures of tem-
poral lobe origin with concurrent cognitive impair-
ment and neuroradiological evidence of
hippocampal atrophy has a broad differential diag-
nosis, encompassing not only an epilepsy syndrome
but also a cognitive disorder. The latter includes
Alzheimer’s disease, the pure hippocampal sclerosis
form of frontotemporal dementia, and autoimmune
(VGKC antibody-mediated) non-paraneoplastic lim-
bic encephalitis. Investigation and follow-up to
establish an aetiological diagnosis is required.References
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